Art. -Nr.: HY-N0036

Costunolide

(Synonyms: (+)-Costunolide; Costus lactone)

6 Cited Publications

Kundenbewertung

Based on 6 publication(s) in Google Scholar

Costunolide ((+)-Costunolide) is a naturally occurring sesquiterpene lactone, with antioxidative, anti-inflammatory, antiallergic, bone remodeling, neuroprotective, hair growth promoting, anticancer, and antidiabetic properties. Costunolide can induce cell cycle arrest and apoptosis on breast cancer cells.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.92%
CAS. Nr.: 553-21-9
Formel: C₁₅H₂₀O₂
Molecular Weight:232.32

Speicherung:

-20°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Costunolide Chemical Structure

CAS. Nr.: 553-21-9

Größe

Preis

Verfügbarkeit

Menge

Sample (0.1mg)

In-stock

(In Japan)

Apply Now

Angebot einholen Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability Angebot einholen Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability

Massenanfrage

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Publications (6)
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

Apoptosis^[2]^[3]

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	12.3 μM Compound: 1	Cytotoxicity against human A549 cell line Cytotoxicity against human A549 cell line	[PMID: 16766184]
C6	IC₅₀	4.1 μM Compound: 1	Cytotoxicity against rat C6 cells Cytotoxicity against rat C6 cells	[PMID: 26226279]
DU-145	IC₅₀	29.2 μM Compound: 1	Cytotoxicity against human DU145 cell line Cytotoxicity against human DU145 cell line	[PMID: 16766184]
HBL-100	IC₅₀	10.3 μM Compound: 1	Cytotoxicity against human HBL100 cell line Cytotoxicity against human HBL100 cell line	[PMID: 16766184]
HL-60	IC₅₀	2.1 μM Compound: 1	Cytotoxicity against human HL60 cells Cytotoxicity against human HL60 cells	[PMID: 26226279]
HL-60	IC₅₀	7.7 μM Compound: 2	Cytotoxicity against human HL60 cells after 18 hrs by annexin-V labeling-based flow cytometry Cytotoxicity against human HL60 cells after 18 hrs by annexin-V labeling-based flow cytometry	[PMID: 22985027]
K562	IC₅₀	14.5 μM Compound: 1	Cytotoxicity against human K562 cell line Cytotoxicity against human K562 cell line	[PMID: 16766184]
KB	ED₅₀	0.57 μg/mL Compound: 4, Costunolide	Cytotoxicity against human KB cells Cytotoxicity against human KB cells	[PMID: 17336532]
KB	ED₅₀	2.46 μM Compound: costunolide	Cytotoxicity against human KB cells Cytotoxicity against human KB cells	[PMID: 18329753]
KB	IC₅₀	28.9 μM Compound: 1	Cytotoxicity against human KB cell line Cytotoxicity against human KB cell line	[PMID: 16766184]
KG-1a	IC₅₀	4.1 μM Compound: 1	Cytotoxicity against human KG1a cells Cytotoxicity against human KG1a cells	[PMID: 26226279]
Macrophage	IC₅₀	1.2 μg/mL Compound: 9	Antiinflammatory activity in mouse macrophages assessed as LPS-induced nitric oxide production Antiinflammatory activity in mouse macrophages assessed as LPS-induced nitric oxide production	10.1039/C2MD20172K
MIA PaCa-2	IC₅₀	17.7 μM Compound: 1	Cytotoxicity against human MiaPaca2 cell line Cytotoxicity against human MiaPaca2 cell line	[PMID: 16766184]
NALM-6	IC₅₀	65 μM Compound: Costunolide	Inhibition of telomerase in human NALM6 cells by TRAP assay Inhibition of telomerase in human NALM6 cells by TRAP assay	10.1039/C0MD00241K
NIH3T3	IC₅₀	13.9 μM Compound: 1	Cytotoxicity against mouse NIH3T3 cell line Cytotoxicity against mouse NIH3T3 cell line	[PMID: 16766184]
PA-1	IC₅₀	10.6 μM Compound: 1	Cytotoxicity against human PA1 cell line Cytotoxicity against human PA1 cell line	[PMID: 16766184]
RAW264.7	IC₅₀	>50 μM Compound: 22	Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay	[PMID: 33939429]
SW-620	IC₅₀	7.8 μM Compound: 1	Cytotoxicity against human SW620 cell line Cytotoxicity against human SW620 cell line	[PMID: 16766184]
T-cell	IC₅₀	2.57 μM Compound: Cos	Immunomodulatory activity in C57BL/6 mouse mesenteric lymph node T cells assessed as inhibition of concanavalin A stimulated T-cell proliferation incubated for 68 hrs by CCK-8 assay Immunomodulatory activity in C57BL/6 mouse mesenteric lymph node T cells assessed as inhibition of concanavalin A stimulated T-cell proliferation incubated for 68 hrs by CCK-8 assay	[PMID: 37017305]

In Vitro

Costunolide inhibits the colony formation, migrative and invasive abilities of the H1299 cells in a dose or time dependent manner^[2].
Costunolide (6.7-215.2 μM; 24 hours) inhibits the viability of H1299 cells in a dose-dependent manner, with an IC₅₀ of 23.93 μM^[2].
Costunolide (12.0-48.0 μM; 48 hours) induces apoptosis in H1299 cells^[2].
Costunolide (12-48.0 μM; 6-12 hours) regulates metastasis- and proliferation-associated mRNA expression^[2].
Costunolide regulates epithelial-to-mesenchymal transition (EMT)-associated protein expression^[2].
Costunolide regulates c-Myc mediated apoptosis signaling and 14-3-3-mediated signaling pathways in breast cancer cells^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[2]

Cell Line:

H1299 cells
Concentration:

6.7 μM, 13.5 μM, 26.9 μM, 107.6 μM, 215.2 μM
Incubation Time:

24 hours
Result:

Inhibited the viability of H1299 cells (MTT assay).

Apoptosis Analysis^[2]

Cell Line:

H1299 cells
Concentration:

0 µM, 12.0 µM, 24.0 µM, 48.0 µM
Incubation Time:

48 hours
Result:

Significantly promoted apoptosis at 24.0 µM and 48.0 µM.

RT-PCR^[2]

Cell Line:

H1299 cells
Concentration:

0 µM, 12.0 µM, 24.0 µM, 48.0 µM
Incubation Time:

6 hours, 12 hours
Result:

Regulated the metastasis- and proliferation-associated mRNA levels in a dose-dependent manner.

Western Blot Analysis^[2]

Cell Line:

H1299 cells
Concentration:

0 µM, 12.0 µM, 24.0 µM, 48.0 µM
Incubation Time:

48 hours
Result:

Significantly inhibited the EMT of H1299 cells.

In Vivo

Costunolide (20 mg/kg; i.p; daily; for 30 days) inhibits breast cancer through c-Myc/p53 and AKT/14-3-3 pathway^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

4 weeks old female BALB/c nude mice, MDA-MB-231 cells xenograft mouse models^[3]
Dosage:

20 mg/kg
Administration:

Intraperitoneal injection, daily, for 30 days
Result:

Reduced the expression levels of c-Myc and p-AKT and elevated the expression levels of p53 and p-14-3-3.

Chemical Information

CAS. Nr. 553-21-9
Appearance Solid
Molecular Weight 232.32
Formel C₁₅H₂₀O₂
Color White to yellow
SMILES

O=C(O[C@@]1([H])[C@@]2([H])CC/C(C)=C/CC/C(C)=C/1)C2=C
Synonyms

(+)-Costunolide; Costus lactone
Structure Classification
- Terpenoids
- Sesquiterpenes
Initial Source
- Plants
- Compositae
- Endogenous metabolite
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

-20°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Publications (6)

All Cell Proliferation/Viability AssayRT-PCRWBBio/Physico-chemical Assay

Sort by:

Journal Impact Factor

Cell Mol Biol Lett

Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2. [Abstract]

2019 Aug 14:24:52. PMID: 31428167

Costunolide purchased from MedChemExpress. Usage Cited in: Cell Mol Biol Lett. 2019 Aug 14:24:52. [Abstract]

Costunolide reduces HSC activation. Primary rat HSCs at passages 3 through 5 were treated with Costunolide (0-30 μM) at the indicated concentrations for 24 h. MTT assay for evaluating cell viability, which is presented as a percentage of the control.

Costunolide purchased from MedChemExpress. Usage Cited in: Cell Mol Biol Lett. 2019 Aug 14:24:52. [Abstract]

Costunolide reduces HSC activation. Primary rat HSCs at passages 3 through 5 were treated with Costunolide (0-30 μM) at the indicated concentrations for 24 h. Real-time PCR for determining the mRNA expression of α-SMA and collagen I.

Costunolide purchased from MedChemExpress. Usage Cited in: Cell Mol Biol Lett. 2019 Aug 14:24:52. [Abstract]

Costunolide reduces HSC activation. Primary rat HSCs at passages 3 through 5 were treated with Costunolide (0-30 μM) at the indicated concentrations for 24 h. Western blot assay for determining the protein expression of α-SMA and collagen I with quantification of the blots.

Costunolide purchased from MedChemExpress. Usage Cited in: Cell Mol Biol Lett. 2019 Aug 14:24:52. [Abstract]

Costunolide blocks aerobic glycolysis in HSCs. Primary rat HSCs at passages 3 through 5 were treated with Costunolide (0-30 μM) at the indicated concentrations for 24 h. Measurement of glucose uptake using absorbance at 570/610 nm.

Costunolide purchased from MedChemExpress. Usage Cited in: Cell Mol Biol Lett. 2019 Aug 14:24:52. [Abstract]

Blockade of aerobic glycolysis contributes to the reduction in HSC activation by costunolide. Primary rat HSCs at passages 3 through 5 were treated with Costunolide (30 μM) and/or 2-DG at the indicated concentrations for 24 h. Real-time PCR for determining the mRNA expression of α-SMA and collagen I.
Phytomedicine

Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation. [Abstract]

2025 May:140:156484. PMID: 40090046
Molecules

Costunolide Plays an Anti-Neuroinflammation Role in Lipopolysaccharide-Induced BV2 Microglial Activation by Targeting Cyclin-Dependent Kinase 2. [Abstract]

2020 Jun 19;25(12):2840. PMID: 32575562
ACS Omega

Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer. [Abstract]

2024 Feb 28;9(10):11870-11882. PMID: 38496939
Gene

Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells. [Abstract]

2018 Dec 15:678:261-269. PMID: 30103008

Costunolide purchased from MedChemExpress. Usage Cited in: Gene. 2018 Dec 15:678:261-269. [Abstract]

Western blot analysis of mTOR phosphorylation at Ser2448 and Ser2481 with quantification.
SSRN

2023 Feb 27.

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 100 mg/mL (430.44 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : 25 mg/mL (107.61 mM; ultrasonic and warming and heat to 60°C)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

4.3044 mL

21.5220 mL

43.0441 mL

5 mM

0.8609 mL

4.3044 mL

8.6088 mL

10 mM

0.4304 mL

2.1522 mL

4.3044 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% EtOH 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (10.76 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% EtOH 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (10.76 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% EtOH 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (10.76 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

Protocol 4

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.08 mg/mL (8.95 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 5

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.08 mg/mL (8.95 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 6

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.08 mg/mL (8.95 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (287 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Dae Yong Kim, et al. Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential. Int J Mol Sci. 2019 Jun; 20(12): 2926. [Content Brief]

[2]. Minyan Wei, et al. Costunolide induces apoptosis and inhibits migration and invasion in H1299 lung cancer cells. Oncol Rep. 2020 Jun;43(6):1986-1994. [Content Brief]

[3]. Zhangxiao Peng, et al. Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.Sci Rep. 2017; 7: 41254. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
Ethanol / DMSO	1 mM	4.3044 mL	21.5220 mL	43.0441 mL	107.6102 mL
	5 mM	0.8609 mL	4.3044 mL	8.6088 mL	21.5220 mL
	10 mM	0.4304 mL	2.1522 mL	4.3044 mL	10.7610 mL
	15 mM	0.2870 mL	1.4348 mL	2.8696 mL	7.1740 mL
	20 mM	0.2152 mL	1.0761 mL	2.1522 mL	5.3805 mL
	25 mM	0.1722 mL	0.8609 mL	1.7218 mL	4.3044 mL
	30 mM	0.1435 mL	0.7174 mL	1.4348 mL	3.5870 mL
	40 mM	0.1076 mL	0.5381 mL	1.0761 mL	2.6903 mL
	50 mM	0.0861 mL	0.4304 mL	0.8609 mL	2.1522 mL
	60 mM	0.0717 mL	0.3587 mL	0.7174 mL	1.7935 mL
	80 mM	0.0538 mL	0.2690 mL	0.5381 mL	1.3451 mL
	100 mM	0.0430 mL	0.2152 mL	0.4304 mL	1.0761 mL

Costunolide

6 Cited Publications

100 mg Angebot einholen

Subscribe to the

MedChemExpress

Newsletter

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Costunolide

Apoptosis Compound Library

Metabolism/Protease Compound Library

Natural Product Library

Anti-Cancer Compound Library

Anti-diabetic Compound Library

Terpenoids Library

Traditional Chinese Medicine Active Compound Library

FDA Approved & Pharmacopeial Drug Library

Neuroprotective Compound Library

Anti-Breast Cancer Compound Library

Food-Sourced Compound Library

Anti-Cancer Natural Product Library

Plant-Sourced Natural Product Library

Human Metabolite Library

Heterocyclic Compound Library

Cell Death Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Miao Ethnicity Medicine Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

RO5 Drug-like Natural Product Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Mass Spectrometry Human Metabolite Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mongolian Medicine Compound Library

Natural Product Diversity Scaffold Library

RNA Binding Bioactive Compound Library

Mass Spectrometry Natural Product Library

Publications Citing Use of MedChemExpress (MCE) Costunolide

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Publications (6)

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

Costunolide Related Classifications

Art. -Nr.: HY-N0036